Find clinical trials for Lung Cancer in Pittsburgh, PA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near Pittsburgh, PA, USA:
a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...
Phase 2
Natrona Heights, Pennsylvania, United States and 83 other locations
This phase II clinical trial will study the safety and efficacy of onvansertib to treat patients with small cell lung cancer (SCLC)...
Phase 2
Pittsburgh, Pennsylvania, United States and 1 other location
the efficacy and safety of an infusion of IOV-4001 in adult participants with unresectable or metastatic melanoma or advanced non-small-cell lung...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 9 other locations
locally advanced or metastatic disease.In addition, HER3-DXd will be evaluated in participants with locally advanced or metastatic NSCLC whose tumors...
Phase 1
Pittsburgh, Pennsylvania, United States and 36 other locations
resectable, early-stage non-small cell lung cancer....
Phase 2
Pittsburgh, Pennsylvania, United States and 97 other locations
Phase 2 Platform Study in Patients with Advanced Non-Small Lung Cancer who progressed on First-Line Osimertinib Therapy. This study...
Phase 2
Pittsburgh, Pennsylvania, United States and 46 other locations
The goal of this Phase 1 clinical study is test tumor infiltrating lymphocytes (known as C-TIL051) with NKTR-255 and anti-PD1 therapy for su ...
Phase 1
Pittsburgh, Pennsylvania, United States and 3 other locations
The main aim of this study is to:* evaluate safety and efficacy (per Response Evaluation Criteria in Solid Tumors version 1.1 \[RECIST 1.1\]...
Phase 2
Pittsburgh, Pennsylvania, United States and 80 other locations
the efficacy and safety of durvalumab and/or novel oncology therapies, with or without chemotherapy, for first-line Stage IV Non-Small Cell Lung...
Phase 1
Pittsburgh, Pennsylvania, United States and 40 other locations
overall response rate (ORR) when compared to nivolumab plus PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung...
Phase 2
Pittsburgh, Pennsylvania, United States and 126 other locations
Clinical trials
Research sites
Resources
Legal